Skip to content
Georgia Commons
Menu

Official Code of Georgia Annotated

Title 31. HEALTH · Chapter 52. TERMINALLY ILL PATIENT’S RIGHT TO TRY INVESTIGATIONAL DRUGS, BIOLOGICAL PRODUCTS, AND DEVICES · Article 1. RIGHT TO TRY

31-52-7. Coverage under health benefit plan permitted but not required.

Active

Current through: Including Acts of the 2025 Session of the General Assembly of Georgia.

  1. A health benefit plan or governmental agency may provide coverage for the cost of any investigational drug, biological product, or device pursuant to this article; provided, however, that nothing in this article shall be construed to require a health benefit plan or governmental agency to provide coverage for the cost of any investigational drug, biological product, or device pursuant to this article.

The notes below are printed with the section but are not enacted law (O.C.G.A. § 1-1-1(c)). They are shown apart from the text.

History

Code 1981, § 31-52-7, enacted by Ga. L. 2016, p. 345, § 1/HB 34; Ga. L. 2025, p. 455, § 3/SB 72, effective July 1, 2025.

Amendments

The 2025 amendment, effective July 1, 2025, substituted “article” for “chapter” in three places in this Code section.

Editor's notes

Ga. L. 2025, p. 455, § 1/SB 72, not codified by the General Assembly, provides: “This Act shall be known and may be cited as the ‘Hope for Georgia Patients Act.’”

Read the official page (the state's PDF, opened at the page this text was read from).

Current through: Including Acts of the 2025 Session of the General Assembly of Georgia.

Text read from t31-(v23)-2025-pdf.pdf, Volume V23, 2025 edition, page 1090; merge action: bound only; file SHA-256 ba5a57f85d04.